Short- to mid-term outcomes after transcatheter aortic valve replacement in patients with ascending aorta dilation: a single-centre retrospective analysis

医学 四分位间距 升主动脉 主动脉瓣狭窄 回顾性队列研究 心脏病学 内科学 主动脉瓣 血管病学 狭窄 主动脉 相伴的 外科
作者
Jun Yu,Wei Wang
出处
期刊:BMC Cardiovascular Disorders [BioMed Central]
卷期号:23 (1) 被引量:3
标识
DOI:10.1186/s12872-023-03063-8
摘要

Abstract Objectives Ascending aorta dilation (AAD) is frequently associated with aortic stenosis (AS). This study investigated the procedural and clinical outcomes of transcatheter aortic valve replacement (TAVR) in patients with AAD for tricuspid AS. Methods This is a single-centre retrospective study that included patients with tricuspid AS and who underwent TAVR between January 1, 2018 and December 31, 2021. A total of 239 patients met the inclusion criteria. The ascending aortic diameter was measured on computed tomography (CT) scans before TAVR, and AAD was identified as a maximal ascending aortic diameter of ≥ 40 mm. The outcomes were in line with the Valve Academy Research Consortium (VARC)-3 criteria. Results Self-expandable (SE) valves were used in 88.7% of the total cohort (89.0% in the AAD group and 88.6% in the non-AAD group). Seventy-three patients (30.5%) were diagnosed with concomitant AAD (mean age 73.7 ± 7.3 years, 57.5% male). The median ascending aortic diameter was 36.0 mm (interquartile range [IQR]: 34.0–37.0 mm) in the non-AAD group and 44.0 mm (IQR: 42.0–46.0 mm) in the AAD group ( p < 0.001). The baseline characteristics were comparable across the groups. No significant difference was observed in cumulative all-cause mortality at 30 days (2.4% vs. 1.4%, p = 0.609), 1 year (9.2% vs. 5.0%, p = 0.191), or 3 years (13.1% vs. 9.5%, p = 0.201) between the non-AAD and AAD groups. The device success rate was not different between the non-AAD and AAD groups (74.7% vs. 82.2%, p = 0.205). The multivariable analysis identified prior percutaneous coronary intervention, prior stroke, and length of intensive care unit as independent predictors of 3-year all-cause mortality among the total cohort. Conclusion AAD does not appear to be associated with the procedural and mid-term clinical outcomes in patients undergoing TAVR.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
Johann完成签到,获得积分10
2秒前
3秒前
半个橙子完成签到 ,获得积分10
4秒前
Zsy完成签到,获得积分10
4秒前
壮观谷冬完成签到,获得积分10
4秒前
5秒前
六六发布了新的文献求助10
5秒前
111完成签到,获得积分10
5秒前
小手冰凉完成签到 ,获得积分10
5秒前
yxhawx完成签到 ,获得积分20
6秒前
Shen完成签到,获得积分10
6秒前
7秒前
sanmu发布了新的文献求助10
7秒前
跳跃完成签到,获得积分10
11秒前
努力的排骨丁完成签到,获得积分10
11秒前
甜甜的曼荷完成签到,获得积分10
12秒前
12秒前
DCC完成签到,获得积分10
12秒前
13秒前
pear完成签到,获得积分10
13秒前
Ze完成签到,获得积分10
14秒前
pengg完成签到,获得积分10
14秒前
袁琴完成签到,获得积分10
14秒前
wuyi完成签到,获得积分10
14秒前
雨品完成签到,获得积分10
14秒前
123321完成签到,获得积分10
14秒前
Bonlin完成签到,获得积分10
16秒前
doomedQL完成签到,获得积分10
17秒前
燕子完成签到 ,获得积分10
17秒前
17秒前
啦啦啦完成签到,获得积分10
17秒前
小白完成签到,获得积分10
18秒前
吴秋阳完成签到 ,获得积分10
18秒前
王老师完成签到 ,获得积分10
18秒前
skycool完成签到,获得积分10
19秒前
lujianqi发布了新的文献求助150
20秒前
晓风完成签到,获得积分0
21秒前
congyang完成签到,获得积分20
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180111
求助须知:如何正确求助?哪些是违规求助? 9570235
关于积分的说明 21809184
捐赠科研通 7776198
什么是DOI,文献DOI怎么找? 3433262
关于科研通互助平台的介绍 2557463
邀请新用户注册赠送积分活动 2479039